Oliver Kent Glass, PhD

Medical Instructor in the Department of Medicine
Campus mail 3475 Erwin Rd., Durham, NC 27710
Phone (919) 660-6672
Email address oliver.glass@duke.edu

My research interests are understanding how and why exercise is effective in chronic disease. I am interested in the unique role of skeletal muscle as a key mediator of exercise effects. 

Education and Training

  • Ph.D., Duke University, 2015

Publications

Glass, O, Radia, A, Kraus, W, and Abdelmalek, M. "Exercise Training as Treatment of Nonalcoholic Fatty Liver Disease." Journal of Functional Morphology and Kinesiology 2, no. 4 (December 2017): 35-35.

Full Text

Glass, OK, Bowie, M, Fuller, J, Darr, D, Usary, J, Boss, K, Choudhury, KR, Liu, X, Zhang, Z, Locasale, JW, Williams, C, Dewhirst, MW, Jones, LW, and Seewaldt, V. "Differential response to exercise in claudin-low breast cancer." Oncotarget 8, no. 60 (November 2017): 100989-101004.

PMID
29254140
Full Text

Glass, OK, Ramalingam, S, and Harrison, MR. "Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss." Clinical advances in hematology & oncology : H&O 14, no. 6 (June 2016): 436-446. (Review)

PMID
27379813
Scholars@Duke

Glass, OK, Inman, BA, Broadwater, G, Courneya, KS, Mackey, JR, Goruk, S, Nelson, ER, Jasper, J, Field, CJ, Bain, JR, Muehlbauer, M, Stevens, RD, Hirschey, MD, and Jones, LW. "Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study." British Journal of Cancer 112, no. 5 (March 2015): 825-831.

PMID
25584487
Full Text

Hartman, ZC, Wei, J, Glass, OK, Guo, H, Lei, G, Yang, X-Y, Osada, T, Hobeika, A, Delcayre, A, Le Pecq, J-B, Morse, MA, Clay, TM, and Lyerly, HK. "Increasing vaccine potency through exosome antigen targeting." Vaccine 29, no. 50 (November 21, 2011): 9361-9367.

PMID
22001882
Full Text

Hartman, ZC, Yang, X-Y, Glass, O, Lei, G, Osada, T, Dave, SS, Morse, MA, Clay, TM, and Lyerly, HK. "HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis." Cancer Res 71, no. 13 (July 1, 2011): 4380-4391.

PMID
21518778
Full Text

Hartman, ZC, Osada, T, Glass, O, Yang, XY, Lei, G-J, Lyerly, HK, and Clay, TM. "Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity." Cancer research 70, no. 18 (September 7, 2010): 7209-7220.

PMID
20823152
Full Text

Hartman, ZC, Wei, J, Osada, T, Glass, O, Lei, G, Yang, X-Y, Peplinski, S, Kim, D-W, Xia, W, Spector, N, Marks, J, Barry, W, Hobeika, A, Devi, G, Amalfitano, A, Morse, MA, Lyerly, HK, and Clay, TM. "An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity." Clin Cancer Res 16, no. 5 (March 1, 2010): 1466-1477.

PMID
20179231
Full Text

Osada, T, Yang, XY, Hartman, ZC, Glass, O, Hodges, BL, Niedzwiecki, D, Morse, MA, Lyerly, HK, Amalfitano, A, and Clay, TM. "Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity." Cancer Gene Ther 16, no. 9 (September 2009): 673-682.

PMID
19229288
Full Text

Hartman, ZC, Appledorn, DM, Serra, D, Glass, O, Mendelson, TB, Clay, TM, and Amalfitano, A. "Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system." Virology 374, no. 2 (May 2008): 453-467.

PMID
18280530
Full Text